QPEX BIOPHARMA, INC.

ACTIVE

11440 W Bernardo Ct Ste 300, 加利福尼亚州圣迭戈县, California, United Stateswww.qpexbio.comSubsidiary11–50 employeesEstablished: 2018-10-01

Part of Shionogi, Inc.

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2018

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Completed

90.0%

Recruiting

10.0%

Clinical Trials

Trials sponsored by this organization (10)

A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment

Phase 1

Recruiting

interventional

Sep 202540 participants

Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male Participants

Phase 1

Completed

interventional

Aug 20258 participants

PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment

Phase 1

Completed

interventional

Nov 202432 participants

A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants

Phase 1

Completed

interventional

Sep 202460 participants

P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

Phase 1

Completed

interventional

Jan 202453 participants

Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects

Phase 1

Completed

interventional

Nov 202112 participants

SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers

Phase 1

Completed

interventional

Jun 2021104 participants

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

Phase 1

Completed

interventional

Apr 202175 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations